Introduction
Diabetes mellitus (DM) is a complex metabolic disease affecting about 422 million people worldwide. It is characterized by chronic hyperglycemia, insulin resistance, and/or insulin secondary deficiency caused by the failure of β-pancreatic cells [
1,
2].
According to the classification proposed by the American Diabetes Association (ADA), there are two DM types: type 1 diabetes and type 2 diabetes are heterogeneous diseases in which clinical presentation and disease progression may vary considerably [
1]. Type 1 diabetes is usually diagnosed in children and adolescents. It is an autoimmune disease characterized by the destruction of β-pancreatic cells by lymphocytes and macrophages resulting in hyperglycemia, usually leading to absolute insulin deficiency [
3]. Type 2 diabetes, which accounts for 90–95% of all cases of DM, occurs due to a progressive loss of β-cell insulin secretion frequently on the background of insulin resistance compensated by increased secretion of insulin [
1,
2]. However, this prolonged overstimulation of insulin secretion leads to progressive exhaustion and degradation of β-cells [
4,
5]. Multiple risk factors for type 2 DM are associated with bad eating habits, increased adiposity and sedentarism, leading to the hypothesis that type II DM is a result of gene-environment interactions [
6,
7].
Different experimental models emerged as possibilities to mimic human types 1 and 2 DM to study its development and complications. Masiello et al. (1998) developed a rat model of diabetes induced by administration of streptozotocin (STZ) and nicotinamide. STZ selectively destroys pancreatic beta cells, while N decrease the damage caused by STZ, creating a state of partial insulin deficiency, similar to what occurs in type 2 diabetes. The severity of STZ + N-induced diabetes is much lower than that of diabetes induced by STZ alone; rats manifest moderate hyperglycemia and do not require exogenous insulin to survive [
8]. Type 2 DM is probably to be as elaborate and heterogeneous as the human condition. Thus, in some animals, insulin resistance predominates, while in others there are predominance of β-cell failure. Models where glucose intolerance is part of a large phenotype, such as: obesity, dyslipidaemia and hypertension may also provide valuable insights into human type 2 DM [
9].
Nicotinamide, a derivative of vitamin B3, effectively protects β-cells against the cytotoxicity of STZ. The protective action of N relies on the decreased damage and deoxyribonucleic acid (DNA) methylation in pancreatic islets, improved insulin secretion [
10,
11], neuroprotection and antioxidant functions [
12].
Although all of these mechanisms play a pivotal role in diabetes development, autonomic nervous system also underlies cardiometabolic pathophysiology in metabolic diseases. Studies in fructose-fed animals demonstrated that autonomic nervous system dysfunction, mainly represented by baroreflex sensitivity impairment, not only accompanies the disease progression but may also precede metabolic and hemodynamics alterations [
13,
14]. Lin et al. (2008) showed early cardiac autonomic dysfunction and baroreflex impairment in diabetic rats pre-treated with nicotinamide; however, rats were anesthetized during the evaluation [
15]. In young adults with diabetic parents compared to non-diabetic parents, autonomic alterations were observed despite differences in baseline glycemia levels [
16].
Since autonomic control of circulation seems to modulate DM complications, and nicotinamide presents a protective role in diabetic rats induced by STZ, we hypothesized that preserved cardiovascular autonomic modulation and baroreflex sensitivity could also mediate the attenuation of STZ-induced derangements in rats pre-treated with nicotinamide. Therefore, this study aimed to evaluate the effect of nicotinamide prior to STZ-induced diabetes in baroreflex sensitivity and cardiovascular autonomic modulation, and its association with hemodynamics and metabolic parameters.
Discussion
Our results confirmed that a single dose of nicotinamide before diabetes induction by STZ can attenuate most of the severe alterations observed in this diabetes model. The main novelty reported by the present study is that this protective effect of nicotinamide was associated with preserved baroreflex sensitivity and parasympathetic modulation. The improvement in these autonomic parameters reflected in better metabolic profile, as observed in the correlation analyses results, and increased survival rate in diabetic rats that received nicotinamide when compared to rats that received only STZ.
It is well known that STZ is a potent cytotoxic drug to pancreatic beta-cells in rats. Briefly, STZ causes DNA damage of insulin-secreting cells, and this injury leads to mechanisms of DNA repair, mitochondria dysfunction and ATP depletion [
32,
33]. As a result, rats present severe diabetes symptoms, similar to what was observed in our STZ animals, as exacerbated levels of glycemia and body weight loss. On the other hand, nicotinamide protects pancreatic beta-cells from DNA damage; therefore, it blunts the development of several STZ-induced diabetes characteristics, as increased hyperglycemia and body weight loss.
In fact, hyperglycemia above 400 mg/dl is usually observed in STZ-induced diabetic rats [
20,
34‐
36] and it is associated with high mortality [
29,
37]. However, in the present study, nicotinamide-induced protective effects seemed to be independent of glycemia levels, as Diab+NicA rats still showed high glycemia values (~ 400 mg/dl) despite being lower than Diab rats. Therefore, we investigated other factors which could mediate the improvements observed in Diab+NicA rats.
It is well known that autonomic dysfunction is in the genesis and progression of several diseases. Parasympathetic dysfunction was associated with insulin resistance in fructose-fed rats [
23]. Indeed, Diab rats presented insulin resistance evidenced by rate constant for insulin tolerance test (kITT), and this parameter was totally normalized in Diab+NicA. Moreover, parasympathetic dysfunction and reflex mechanisms impairments in STZ-induced diabetic rats have already been reported [
20,
34,
37,
38]. This impairment may be a result of alterations in both the efferent limb of the reflex arc, and the central nervous system [
39].
Baroreflex sensitivity impairment in the STZ model of diabetes has also been described [
15,
29,
30,
37]. In our study, only the bradycardic response was impaired. This corroborates with the autonomic modulation profile of the studied rats, as in diabetic rats parasympathetic modulation was reduced. Even though Diab+NicA rats were still hyperglycemic, glycemia was about 20% lower than Diab rats. De Angelis et al. (2002) demonstrated that a better glycemic control is related to baroreflex sensitivity and autonomic improvements [
39].
Accordingly, we found important associations between insulin resistance evaluated by kITT and RMSSD, a time-domain index of cardiac parasympathetic modulation. Also, kITT was associated with the index of reflex bradycardia, showing the interaction between insulin resistance and reflex control of blood pressure. Mechanisms underlying this association are not fully understood; however, some studies have demonstrated that improvements in cardiac oxidative stress profile may contribute to an optimal baroreflex sensitivity and insulin action in aged rats [
40,
41].
STZ-induced diabetic rats also presented hemodynamic alterations which are closely related to autonomic dysfunction. Resting bradycardia and blood pressure decrease is a frequent observation [
29,
37,
38,
42]. Mostarda et al. (2009) showed that resting bradycardia in diabetic rats occurs due to decreased intrinsic heart rate, while decreased blood pressure is linked to a reduction in cardiac output [
29].
Cardiac function in STZ-induced diabetic may also be impaired, as systolic and diastolic dysfunctions have been described [
28,
43]. Indeed, Diab rats had decreased IVRT and E/IVRT ratio, indicating diastolic dysfunction. We did not find systolic dysfunction or expressive morphological abnormalities; however, our follow-up period was shorter than other studies.
Diabetes patients present high levels of mortality mainly due to cardiovascular complications [
1]. In asymptomatic individuals, it was observed that up to 20% of them presented impairment of cardiovascular autonomic function [
44]. This information highlights the importance of neuropathy in the time course of diabetic disease.
Another characteristic of diabetes is body weight loss. In our study, rats that received nicotinamide were able to maintain body weight stable throughout the studied period, while, as expected, diabetic rats had a severe weight loss (> 40%). Guo et al. (2019) reported that nicotinamide had a protective effect on skeletal muscle atrophy in STZ-induced diabetic mice, which may be through inhibition of TGF-b1/Smad2 pathway [
45]. Preservation of body mass seems to be an important feature in diabetes. The correlation analyses showed that diabetic rats with preserved body weight mass presented increased baroreflex sensitivity, increased RMSSD, and decreased insulin resistance.
Altogether, the improvements induced by nicotinamide in diabetic rats resulted in increased survival rate. In 13 weeks, survival in STZ-induced diabetic rats was approximately 50% [
29]. In our study, Diab rats survival rate in 5 weeks was 70%, while Diab+NicA rats presented 100% survival rate in the same period. Indeed, nicotinamide in addition to intensive insulin therapy during 2 years after type 1 DM diagnosis may improve metabolic control [
46]. In contrast, 12 weeks supplementation of dietary nicotinamide riboside did not improve insulin sensitivity and other metabolic parameters in obese insulin resistance men [
47]. Our new data showing improvement of autonomic modulation and in mortality in nicotinamide-treated animals may indicate a protective action that should be tested in long-term studies.
Diabetes induced by STZ and nicotinamide remains stable for a long time and thus this model of diabetes is suitable not only for short-term but also for long-term studies. Moreover, this model is very useful in investigations of different aspects of diabetes, including diabetic complications and anti-diabetic properties of new drugs and natural compounds [
48].
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.